New stem cell particle injection could soothe severe eczema
Disease control
Recruiting now
This early-stage trial tests an experimental injection called BxC-I17e, made from stem cell particles, in 45 adults with moderate to severe eczema (atopic dermatitis) who haven't responded well to standard creams. The main goal is to check safety and tolerability, with a small lo…
Phase: PHASE1 • Sponsor: Brexogen Inc. • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC